ABSTRACT
The study presented here considers the analysis of a medical dataset for the identification of the stage of onset of COVID-19 coronavirus. These data, presented in previous work by the authors, have been subjected to extensive analysis and additional calculations. The data were obtained by analyzing blood samples of infected individuals at 1, 3, and 6 months after COVID-19 infection. Results were obtained from FTIR spectrometry experiments. The results indicate a very effective ability to identify the different states of infection, and between 1 and 6 months even perfect. Specific spectrometry wavelength ranges can also be distinguished as medical markers.
ABSTRACT
The study presented here considers the analysis of a medical dataset for the identification of the stage of onset of COVID-19 coronavirus. These data, presented in previous work by the authors, have been subjected to extensive analysis and additional calculations. The data were obtained by analyzing blood samples of infected individuals at 1, 3, and 6 months after COVID-19 infection. Results were obtained from FTIR spectrometry experiments. The results indicate a very effective ability to identify the different states of infection, and between 1 and 6 months even perfect. Specific spectrometry wavelength ranges can also be distinguished as medical markers.
ABSTRACT
In this research, blood samples of 47 patients infected by COVID were analyzed. The samples were taken on the 1st, 3rd and 6th month after the detection of COVID infection. Total antibody levels were measured against the SARS-CoV-2 N antigen and surrogate virus neutralization by serological methods. To differentiate COVID patients with different antibody levels, Fourier Transform InfraRed (FTIR) and Raman spectroscopy methods were used. The spectroscopy data were analyzed by multivariate analysis, machine learning and neural network methods. It was shown, that analysis of serum using the above-mentioned spectroscopy methods allows to differentiate antibody levels between 1 and 6 months via spectral biomarkers of amides II and I. Moreover, multivariate analysis showed, that using Raman spectroscopy in the range between 1317 cm-1 and 1432 cm-1, 2840 cm-1 and 2956 cm-1 it is possible to distinguish patients after 1, 3, and 6 months from COVID with a sensitivity close to 100%.